276 related articles for article (PubMed ID: 32757303)
1. Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease.
Gallais Sérézal I; Cheuk S; Martini E; Eidsmo L
Scand J Immunol; 2020 Nov; 92(5):e12953. PubMed ID: 32757303
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.
Cheuk S; Wikén M; Blomqvist L; Nylén S; Talme T; Ståhle M; Eidsmo L
J Immunol; 2014 Apr; 192(7):3111-20. PubMed ID: 24610014
[TBL] [Abstract][Full Text] [Related]
4. Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome.
Gallais Sérézal I; Classon C; Cheuk S; Barrientos-Somarribas M; Wadman E; Martini E; Chang D; Xu Landén N; Ehrström M; Nylén S; Eidsmo L
J Invest Dermatol; 2018 Aug; 138(8):1754-1763. PubMed ID: 29510191
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis: the epidermal component.
Tschachler E
Clin Dermatol; 2007; 25(6):589-95. PubMed ID: 18021897
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of CD99 expression in the skin of psoriasis patients].
Belonogov RN; Ruksha TG
Arkh Patol; 2013; 75(5):26-9. PubMed ID: 24341229
[TBL] [Abstract][Full Text] [Related]
7. The cytokine and chemokine network in psoriasis.
Nickoloff BJ; Xin H; Nestle FO; Qin JZ
Clin Dermatol; 2007; 25(6):568-73. PubMed ID: 18021894
[TBL] [Abstract][Full Text] [Related]
8. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
Sa SM; Valdez PA; Wu J; Jung K; Zhong F; Hall L; Kasman I; Winer J; Modrusan Z; Danilenko DM; Ouyang W
J Immunol; 2007 Feb; 178(4):2229-40. PubMed ID: 17277128
[TBL] [Abstract][Full Text] [Related]
9. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
[TBL] [Abstract][Full Text] [Related]
10. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
11. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
Pasquali L; Srivastava A; Meisgen F; Das Mahapatra K; Xia P; Xu Landén N; Pivarcsi A; Sonkoly E
Acta Derm Venereol; 2019 Feb; 99(2):196-205. PubMed ID: 30320872
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.
Swindell WR; Johnston A; Voorhees JJ; Elder JT; Gudjonsson JE
BMC Genomics; 2013 Aug; 14():527. PubMed ID: 23915137
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
Fitch E; Harper E; Skorcheva I; Kurtz SE; Blauvelt A
Curr Rheumatol Rep; 2007 Dec; 9(6):461-7. PubMed ID: 18177599
[TBL] [Abstract][Full Text] [Related]
14. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
Albanesi C; De Pità O; Girolomoni G
Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
[TBL] [Abstract][Full Text] [Related]
15. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
[TBL] [Abstract][Full Text] [Related]
16. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.
Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J
J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte: A trigger or an executor of psoriasis?
Ni X; Lai Y
J Leukoc Biol; 2020 Aug; 108(2):485-491. PubMed ID: 32170886
[TBL] [Abstract][Full Text] [Related]
18. Different cutaneous innate immunity profiles in acne patients with and without atrophic scars.
Saint-Jean M; Khammari A; Jasson F; Nguyen JM; Dréno B
Eur J Dermatol; 2016; 26(1):68-74. PubMed ID: 27018005
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
